Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
61°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
August 26, 2025
Tags
Social issues
Eli Lilly and Co
Healthy Returns
From
CNBC.com News
Trump fires Fed's Cook, Musk sues Apple and OpenAI, Netflix's theatrical run and more in Morning Squawk
August 26, 2025
Tags
Economy
Business News
Politics
From
CNBC.com News
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
August 26, 2025
Tags
US: News
Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
A world on weight loss drugs: How GLP-1s are reshaping the economy
August 26, 2025
Tags
Travel
Novo Nordisk A/S
Food and Beverage
From
CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
August 24, 2025
Tags
Health care industry
Health & Science
Companies
From
CNBC.com News
CNBC's UK Exchange newsletter: The price is REIT
August 20, 2025
Tags
Business News
Business
Europe Politics
From
CNBC.com News
FDA approves first-ever glucose monitoring system for weight loss from Signos
August 20, 2025
Tags
Health care industry
Companies
Health & Science
From
CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
August 19, 2025
Tags
Health & Science
Companies
Health care industry
From
CNBC.com News
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
August 18, 2025
Tags
Biotech and Pharmaceuticals
Business News
Novo Nordisk A/S
From
CNBC.com News
'Don't quit the market' when it's frothy, says Jim Cramer. Here's why
August 14, 2025
Tags
Investment Strategy
Figma Inc
Stock markets
From
CNBC.com News
Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs
August 14, 2025
Tags
Business News
Breaking News: Business
Biotechnology
From
CNBC.com News
Cramer's Lightning Round: Affirm is a buy
August 11, 2025
Tags
Stock markets
Investment Strategy
U/S/ Markets
From
CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
August 07, 2025
Tags
Dine Brands Global
Business
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
August 07, 2025
Tags
Health care industry
Companies
Health & Science
From
CNBC.com News
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
August 07, 2025
Tags
Health care industry
Companies
Health & Science
From
CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
August 05, 2025
Tags
Healthy Returns
Social issues
Biotech and Pharmaceuticals
From
CNBC.com News
5 things to know before the Monday open: Berkshire's tariff fears | Ethereum turns 10 | Restaurants embrace spicy
August 04, 2025
Tags
Business News
McDonald's Corp
Politics
From
CNBC.com News
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
August 01, 2025
Tags
Caterpillar Inc
Warner Bros Discovery Inc
McDonald's Corp
From
CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
August 01, 2025
Tags
Pfizer Inc
GSK plc
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
July 31, 2025
Tags
Eli Lilly and Co
US: News
Pharmaceuticals
From
CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
July 29, 2025
Tags
Novartis AG
Roche Holding AG
Business News
From
CNBC.com News
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
July 20, 2025
Tags
Biotech and Pharmaceuticals
Business News
Breaking News: Business
From
CNBC.com News
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
July 16, 2025
Tags
Social issues
Eli Lilly and Co
Healthy Returns
From
CNBC.com News
Cramer's Lightning Round: Rocket Lab is a buy
July 11, 2025
Tags
Markets
stocks
Investing
From
CNBC.com News
Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning
July 11, 2025
Tags
Eli Lilly and Co
Europe News
Johnson & Johnson
From
CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
July 09, 2025
Tags
Health & Science
Companies
Health care industry
From
CNBC.com News
Trump threatens to put up to 200% tariff on pharmaceuticals 'very soon'
July 08, 2025
Tags
Eli Lilly and Co
Pharmaceuticals
US: News
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 01, 2024
Tags
Nike Inc
Jack in the Box Inc
Exxon Mobil Corp
From
CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
October 01, 2024
Tags
Breaking News: Economy
Labor Unions
Health Care Supplies
From
CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
October 01, 2024
Tags
Strikes
Transportation
Walmart Inc
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.